US Edition
InGeneron Publishes Landmark Study Demonstrating Structural Tendon Regeneration with Autologous Cell Therapy System
Summary by Hastings Tribune
2 Articles
2 Articles
InGeneron Publishes Landmark Study Demonstrating Structural Tendon Regeneration with Autologous Cell Therapy System – Ortho Spine News
HOUSTON, July 23, 2025 -(BUSINESS WIRE)- InGeneron, Inc., a biotechnology company pioneering autologous regenerative cell therapies, today announced the publication of a pivotal preclinical study in the International Journal of Molecular Sciences, further validating the regenerative mechanism of its proprietary cell therapy platform for tendon repair. The study, titled “Regeneration of Biomechanically Functional Tendon Tissue Following Injection
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
